Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Purple Biotech Ltd. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q1 2024
- Shares held
- 1.91M
- −729.9K (−27.7%) vs. Q1 2024
- Total value
- $775.9K
- −$991.8K (−56.1%) vs. Q1 2024
- New holders
- 3
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 708 | $0 | 0.00% | +708 | New |
| Rhumbline Advisers | 16 | $6 | 0.00% | 00.0% | Unchanged |
| Aviso Financial Inc. | 51 | $20 | 0.00% | +51 | New |
| Sound Income Strategies, LLC | 100 | $41 | 0.00% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 300 | $122 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 336 | $137 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 400 | $166 | 0.00% | −2,806−87.5% | Reduced |
| JPMorgan Chase & Co | 859 | $356 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,158 | $1.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 4,000 | $1.44K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 10,000 | $4.07K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 13,739 | $5.00K | 0.00% | +13,739 | New |
| UBS Group AG | 12,852 | $5.23K | 0.00% | +1,241+10.7% | Added |
| Geode Capital Management, LLC | 12,666 | $5.26K | 0.00% | 00.0% | Unchanged |
| Wealth Advisors of Iowa, LLC | 14,270 | $5.81K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 19,273 | $8.00K | 0.00% | +3,195+19.9% | Added |
| Venture Visionary Partners LLC | 22,161 | $9.02K | 0.00% | +6,608+42.5% | Added |
| Citadel Advisors LLC | 24,628 | $10.2K | 0.00% | −33,395−57.6% | Reduced |
| Morgan Stanley | 203,000 | $82.6K | 0.00% | +66,390+48.6% | Added |
| Kingswood Wealth Advisors, LLC | 208,060 | $84.7K | 0.01% | +21,960+11.8% | Added |
| Armistice Capital, LLC | 1,358,000 | $552.7K | 0.01% | −757,000−35.8% | Reduced |
| XTX Topco Ltd | 0 | $0 | 0.00% | −29,099−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −21,438−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |